Location History:
- Killen, AL (US) (2001)
- Salt Lake City, UT (US) (2005)
- Bethesda, MD (US) (2009 - 2013)
- Chevy Chase, MD (US) (1993 - 2014)
- New York City, NY (US) (2014)
- New York, NY (US) (2011 - 2015)
Company Filing History:
31 out of 3,435 
3 out of 1,012 
2 out of 1,215 
Years Active: 1993-2015
Title: John B Robbins: A Prolific Innovator in Vaccines and Therapeutic Conjugates
Introduction:
John B Robbins, an accomplished researcher and inventor, has made significant contributions to the fields of vaccines and therapeutic conjugates. With a rich portfolio of patents and a career marked by fruitful collaborations with renowned institutions and organizations, Robbins' work has played a crucial role in developing pharmaceutical compositions and vaccines for diseases like cholera caused by Vibrio cholerae.
Latest Patents:
Robbins' latest patents highlight his focus on developing conjugates of the capsular polysaccharide of Vibrio cholerae O139 and related oligo- or polysaccharides. These conjugates have shown promise as pharmaceutical compositions and vaccines for preventing, treating, and reducing the severity of cholera infections. Additionally, these patents also detail diagnostic tests for cholera, utilizing the oligo- or polysaccharide-carrier conjugates or associated antibodies.
Career Highlights:
Throughout his career, John B Robbins has actively pursued groundbreaking research and made remarkable contributions to the field. With an impressive total of 37 patents to his name, he has demonstrated his expertise in vaccine development and therapeutic conjugates. Robbins' patents reflect his dedication to finding innovative solutions for infectious diseases, particularly cholera caused by Vibrio cholerae.
Collaborations:
John B Robbins has enjoyed fruitful collaborations with esteemed institutions and organizations in advancing his research and innovations. Notably, he has worked closely with the United States of America, as represented by the Secretary, Department of Health and Human Services. These collaborations have allowed for the translation of Robbins' research into practical applications and have furthered the development of vital healthcare tools.
Furthermore, Robbins has collaborated with colleagues such as Rachel Schneerson and Joanna Kubler-Kielb., who have contributed significantly to the shared objectives of developing vaccines and therapeutic conjugates.
Conclusion:
John B Robbins' pioneering work in vaccines and therapeutic conjugates has earned him recognition as an influential inventor in the field. His patents, focusing on the development of pharmaceutical compositions and vaccines for cholera, stand as a testament to his dedication and expertise. Alongside his collaborations with esteemed institutions, Robbins has significantly contributed to advancements in public health and disease prevention.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.